4//SEC Filing
TREU JESSE I 4
Accession 0000904454-20-000398
CIK 0001341235other
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 4:49 PM ET
Size
10.3 KB
Accession
0000904454-20-000398
Insider Transaction Report
Form 4
TREU JESSE I
Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2020-06-09+2,311→ 2,311 totalExercise: $5.02From: 2021-06-09Exp: 2030-06-08→ Common Stock (2,311 underlying) - Award
Stock Option (right to buy)
2020-06-09+2,465→ 2,465 totalExercise: $5.02From: 2021-06-09Exp: 2030-06-08→ Common Stock (2,465 underlying) - Award
Stock Option (right to buy)
2020-06-09+26,503→ 26,503 totalExercise: $5.02From: 2021-06-09Exp: 2030-06-08→ Common Stock (26,503 underlying)
Footnotes (3)
- [F1]The option is exercisable in full on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer as a member of the Board of Directors through such vesting date.
- [F2]The option is exercisable in full on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer as the chairman of the Nominating and Corporate Governance Committee of the Board of Directors through such vesting date.
- [F3]The option is exercisable in full on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service to the Issuer as a member of the Audit Committee of the Board of Directors through such vesting date.
Documents
Issuer
Aldeyra Therapeutics, Inc.
CIK 0001341235
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001013425
Filing Metadata
- Form type
- 4
- Filed
- Jun 10, 8:00 PM ET
- Accepted
- Jun 11, 4:49 PM ET
- Size
- 10.3 KB